רווח נקי למניה (EPS TTM): Apogee Pharma (APGE)

The fundamental net income per share TTM metric on the GURU.Markets chart demonstrates yield dynamics, where the -4.33 level represents the current value. Apogee Therapeutics (APGE) focuses on developing biologics with infrequent injection intervals for skin therapy. Its status as a scientific pioneer in dermatitis treatment strengthens shareholder confidence, while operational activities rely on strict oversight of external research contractors.
פילוחי מדדים מקיפים ואנליטיקה עבור Apogee Corp (APGE)

For Apogee Therapeutics (APGE), whose model is based on high-risk clinical trials and capital burn, this indicator reflects the actual profit per share over a rolling year. By analyzing the trend of annual net income per share, an investor sees a smoothed dynamic of business efficiency, where any downward momentum signals a critical increase in costs or operating losses.